Protected Phenol Morphinan Synthesis Reducing POCl3
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current methods for synthesizing 3,4-dihydroisoquinolines require high temperatures, excessive POCl3, longer reaction times, and additional synthetic steps due to the presence of free phenol groups, leading to decreased yields and purification difficulties.
Innovation Solution
A process involving the reaction of phenyl acetic acid derivatives with phenethylamine derivatives under controlled conditions, using protected phenol groups to reduce POCl3 usage, reaction time, and temperature, and eliminating the need for additional synthetic steps by performing the reaction in one vessel without intermediate isolation.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Productivity
If free phenol groups are present in the acid during Bischler-Napieralski cyclization, then the cyclization can proceed, but excessive POCl3 is required, reaction time increases, and reaction temperature must be raised
Solution Approach 1:
The phenol group is protected as an ether derivative before the Bischler-Napieralski cyclization step. This preliminary protection prevents the phenol from reacting with POCl3, allowing the cyclization to proceed with reduced POCl3 consumption and shorter reaction time while maintaining the desired reaction rate
2Productivity
If free phenol groups are present in the acid during Bischler-Napieralski cyclization, then the cyclization can proceed, but reaction time increases and higher temperatures are needed
Solution Approach 1:
The phenol group is protected as an ether derivative before cyclization, preventing side reactions that would require higher temperatures. This allows the Bischler-Napieralski cyclization to proceed at lower temperatures while maintaining efficient reaction rates
3Productivity
If protecting groups are used to reduce POCl3 consumption and reaction time, then cyclization efficiency improves, but additional synthetic steps with harsh reagents are required
Solution Approach 1:
The protecting group is selectively removed under mild basic conditions after cyclization, separating the deprotection step from the harsh reagents used in traditional methods. This allows efficient cyclization while minimizing overall process complexity and avoiding harsh deprotection conditions
4Productivity
If free phenol groups are present during cyclization, then the reaction can proceed, but purification becomes difficult and yields decrease
Solution Approach 1:
The phenol group is protected as an ether derivative before cyclization, preventing the formation of complex side products that would be difficult to purify. This preliminary protection simplifies the purification process and increases the yield of the desired dihydroisoquinoline product
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
This method achieves higher yields and simplified work-up and isolation of 3,4-dihydroisoquinolines, reducing the need for harsh reagents and conditions, and allows for the production of high-quality crystals with improved reaction efficiency.
Implementation Method 1
the reaction of phenyl acetic acid derivatives with phenethylamine derivatives
Implementation Method 2
The Bischler-Napieralski cyclization generally converts an appropriately substituted amide to a 3,4-dihydroisoquinoline
Data Source
AI summary
The present invention is directed to processes for the synthesis of morphinans. In particular, a process for coupling a carboxylic acid compound with an amine compound to form an amide product that can then be isolated or the crude amide product can be cyclized to form a 3,4-dihydroisoquinoline. In one embodiment, the carboxylic acid contains a phenol moiety protected with a labile protecting group. The protected phenol reduces reaction times, simplifies work-up of the product, and reduces the amount of cyclizing agent, POCl3 that is necessary to form the 3,4-dihydroisoquinoline.